Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

France’s biotech sector continues to evolve, blending a strong academic foundation with a growing number of startups tackling diverse disease areas. While funding remains a significant hurdle, ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

In April, the major pharma giants in the mergers and acquisitions (M&As) space were Novartis and Merck. Last month, however, the big names that announced multimillion-dollar buyouts were GSK, Sanofi, ...